pI: 6.5029 |
Length (AA): 676 |
MW (Da): 76012 |
Paralog Number:
0
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 8 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
42 | 675 | 1y79 (1) | 1 | 673 | 18.00 | 0 | 1 | 0.96 | -0.51 |
50 | 666 | 1y79 (1) | 83 | 664 | 20.00 | 0 | 1 | 1.1 | -0.4 |
62 | 675 | 1s4b (P) | 29 | 672 | 21.00 | 0 | 1 | 1 | -0.71 |
42 | 675 | 5l44 (A) | 11 | 665 | 18.00 | 0 | 1 | 0.98517 | -0.15 |
42 | 675 | 4ka7 (A) | 94 | 779 | 17.00 | 0 | 1 | 0.98417 | -0.24 |
47 | 675 | 2o3e (A) | 15 | 673 | 22.00 | 0 | 1 | 1.03777 | -0.25 |
75 | 675 | 5l44 (A) | 117 | 665 | 19.00 | 0 | 1 | 1.04165 | 0.03 |
184 | 619 | 4ka7 (A) | 320 | 719 | 28.00 | 0 | 1 | 0.79427 | 0.43 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128475)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G51540 | zincin-like metalloproteases family protein |
Babesia bovis | BBOV_III002610 | peptidase family M3 containing protein |
Brugia malayi | Bm1_11870 | Peptidase family M3 containing protein |
Candida albicans | CaO19.8786 | Mitochondrial intermediate peptidase precursor |
Candida albicans | CaO19.1195 | Mitochondrial intermediate peptidase precursor |
Caenorhabditis elegans | CELE_Y67H2A.7 | Protein Y67H2A.7 |
Dictyostelium discoideum | DDB_G0295743 | peptidase M3A and M3B domain-containing protein |
Drosophila melanogaster | Dmel_CG7791 | CG7791 gene product from transcript CG7791-RA |
Echinococcus granulosus | EgrG_000491800 | mitochondrial intermediate peptidase |
Echinococcus multilocularis | EmuJ_000491800 | mitochondrial intermediate peptidase |
Homo sapiens | ENSG00000027001 | mitochondrial intermediate peptidase |
Leishmania braziliensis | LbrM.35.4690 | mitochondrial intermediate peptidase, putative,metallo-peptidase, Clan MA(E), Family M3 |
Leishmania donovani | LdBPK_364670.1 | mitochondrial intermediate peptidase, putative |
Leishmania infantum | LinJ.36.4670 | mitochondrial intermediate peptidase, putative,metallo-peptidase, Clan MA(E), Family M3 |
Leishmania major | LmjF.36.4450 | mitochondrial intermediate peptidase, putative,metallo-peptidase, Clan MA(E), Family M3 |
Leishmania mexicana | LmxM.36.4450 | mitochondrial intermediate peptidase, putative,metallo-peptidase, Clan MA(E), Family M3 |
Loa Loa (eye worm) | LOAG_02623 | peptidase family M3 containing protein |
Mus musculus | ENSMUSG00000021993 | mitochondrial intermediate peptidase |
Neospora caninum | NCLIV_034640 | peptidase family M3 domain containing protein, putative |
Oryza sativa | 4341884 | Os06g0686500 |
Onchocerca volvulus | OVOC9353 | Mitochondrial intermediate peptidase homolog |
Plasmodium berghei | PBANKA_1350800 | mitochondrial intermediate peptidase, putative |
Plasmodium falciparum | PF3D7_1337000 | mitochondrial intermediate peptidase, putative |
Plasmodium knowlesi | PKNH_1264300 | mitochondrial intermediate peptidase, putative |
Plasmodium vivax | PVX_082780 | mitochondrial intermediate peptidase, putative |
Plasmodium yoelii | PY06253 | hypothetical protein |
Saccharomyces cerevisiae | YKL134C | Oct1p |
Schistosoma japonicum | Sjp_0131320 | ko:K01410 mitochondrial intermediate peptidase [EC3.4.24.59], putative |
Schistosoma japonicum | Sjp_0209760 | ko:K01410 mitochondrial intermediate peptidase [EC3.4.24.59], putative |
Schistosoma mansoni | Smp_075220.1 | mitochondrial intermediate peptidase (M03 family) |
Schistosoma mansoni | Smp_075220.3 | mitochondrial intermediate peptidase (M03 family) |
Schistosoma mansoni | Smp_075220.2 | mitochondrial intermediate peptidase (M03 family) |
Schmidtea mediterranea | mk4.037705.00 | Mitochondrial intermediate peptidase |
Schmidtea mediterranea | mk4.022534.00 | Mitochondrial intermediate peptidase |
Schmidtea mediterranea | mk4.003170.03 | |
Schmidtea mediterranea | mk4.007791.00 | Mitochondrial intermediate peptidase |
Trypanosoma brucei gambiense | Tbg972.10.11990 | mitochondrial intermediate peptidase, putative,metallo-peptidase, Clan MA(E) Family M3 |
Trypanosoma brucei | Tb927.10.9820 | mitochondrial intermediate peptidase, putative |
Trypanosoma brucei | Tb11.v5.0565 | mitochondrial intermediate peptidase, putative |
Trypanosoma cruzi | TcCLB.504147.80 | mitochondrial intermediate peptidase, putative |
Toxoplasma gondii | TGME49_272670 | peptidase family M3 protein |
Theileria parva | TP01_0515 | mitochondrial intermediate peptidase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.9820 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.9820 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.9820 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.9820 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1350800 | Plasmodium berghei | Essential | plasmo |
TGME49_272670 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.